Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
A Phase 2 study evaluating the safety and efficacy of multiple doses of BT061 in adults with moderate-to-severe chronic plaque psoriasis has…
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis [Phase 4]
Phase 4 trial evaluating the immune response to a pneumococcal vaccine in adults treated with alefacept for chronic plaque psoriasis. The st…
-
CLINICAL_TRIALS trial_result · 2012-01-30Clinical Trial Update: A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate [Phase 4]
Phase 4 study evaluating safety and efficacy of ustekinumab in plaque psoriasis patients with an inadequate response to methotrexate; result…
-
CLINICAL_TRIALS research · 2012-01-19Clinical Trial Update: Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis
A clinical trial update presenting classification and characterization of patients treated with efalizumab for plaque psoriasis.
-
FDA approval · 2011-12-26FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-12-13FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program
A clinical trial update for Amevive under the A.W.A.R.E. program has completed, focusing on plaque psoriasis.
-
CLINICAL_TRIALS withdrawal · 2011-10-21Clinical Trial Update: Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates. [Phase 1]
A Phase 1 open-label, single-dose study evaluating briakinumab's drug-drug interaction with CYP substrates in patients with plaque psoriasis…
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis [Phase 4]
This Phase 4 trial evaluated the efficacy and tolerability of topical therapies for plaque psoriasis, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-09-26Clinical Trial Update: Safety and Efficacy Study of CF101 to Treat Psoriasis [Phase 2]
Phase 2 clinical trial evaluating CF101 for safety and efficacy in treating plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-09-26Clinical Trial Update: An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis [Phase 2]
A Phase 2 open-label trial evaluating a treatment for moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)
This five-year observational study reports results for Remicade (infliximab) in plaque psoriasis in Austria. The trial is completed and resu…
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of cyclosporine A microemulsion as maintenance therapy in adults with chronic plaque psori…
-
CLINICAL_TRIALS other · 2011-06-20Clinical Trial Update: Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis
An open clinical study evaluating non-inferiority for chronic plaque psoriasis has been suspended. The sponsor is Glenmark Farmacêutica Ltda…
-
CLINICAL_TRIALS trial_result · 2011-06-03Clinical Trial Update: Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis [Phase 4]
Phase 4 trial update assessing safety and efficacy of two regimens for Vectical ointment and Clobex spray in moderate plaque psoriasis; resu…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis [Phase 3]
This entry reports the completion of a Phase 3 trial assessing the safety and effectiveness of infliximab in plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis [Phase 2]
A Phase 2 dose-effect study of COL-121 ointment in plaque-type psoriasis has completed. The sponsor is Deltanoid Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects [Phase 4]
Phase 4 trial comparing alefacept plus narrow-band UV-B phototherapy to alefacept alone in chronic plaque psoriasis completed; results were …
-
FDA approval · 2011-02-25FDA Approved: TAZORAC — Supplemental Application (Almirall, LLC)
The FDA approved a supplemental application for TAZORAC (tazarotene) from Almirall, LLC.
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis [Phase 2]
This document describes a Phase 2 clinical trial evaluating RWJ-445380 for plaque psoriasis, and notes that the study has completed. The foc…
-
FDA approval · 2011-02-17FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., signaling a labeling update or expansion of its appro…
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp [Phase 4]
Phase 4 clinical trial assessing safety and efficacy of efalizumab in adults with moderate-to-severe plaque psoriasis with scalp involvement…
-
FDA approval · 2010-12-28FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved Janssen Biotech, Inc.'s supplemental application for infliximab. The approval updates the product's labeling and indications as…
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: BTT1023 in Psoriasis [Phase 1]
Biotie Therapies completed a Phase 1 study of BTT1023 in plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2010-11-03Clinical Trial Update: Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of M518101 in plaque psoriasis has completed.